Hence, since ovarian stromal cells do not immunohistochemically express Her2/neu [32], Her2/neu-targeting NIRF probes will detect metastatic breast cancer cells within ovarian tissues if these cells show immunohistochemical reactivity. The gene discussed is ERBB2; the disease is breast carcinoma.